Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.49 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 42.26.
Market Cap
8.49T
Revenue
4.52T
Profits
200.82B
PE Ratio
42.26
Profit Margin
4.44%
Dividend Yield
0.42%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 829.52B | 2.55% | 3,263,730 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 564.05B | -0.15% | 8,945,253 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 368.57B | -0.29% | 8,985,049 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 317.87B | 2.16% | 1,240,696 | 58.74B |
| 5 | UNH | UnitedHealth Group Incorporated | 294.66B | 2.60% | 9,404,361 | 447.57B |
| 6 | MRK | Merck & Co., Inc. | 294.09B | 3.13% | 16,193,678 | 65.01B |
| 7 | NVS | Novartis AG | 290.89B | 1.50% | 1,070,220 | 56.67B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 195.70B | 2.05% | 1,988,030 | 44.56B |
| 9 | AMGN | Amgen Inc. | 191.75B | 1.69% | 2,160,752 | 36.75B |
| 10 | NVO | Novo Nordisk A/S | 182.48B | -1.00% | 12,113,586 | 48.59B |
| 11 | GILD | Gilead Sciences, Inc. | 170.84B | -0.66% | 7,344,679 | 29.44B |
| 12 | ABT | Abbott Laboratories | 168.61B | 1.40% | 17,557,965 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 166.65B | 2.43% | 2,697,624 | 10.06B |
| 14 | PFE | Pfizer Inc. | 156.77B | 1.25% | 30,041,027 | 62.58B |
| 15 | DHR | Danaher Corporation | 137.82B | 0.50% | 4,243,267 | 24.57B |
| 16 | SYK | Stryker Corporation | 131.49B | 1.46% | 2,477,902 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 122.85B | 2.05% | 11,534,919 | 48.19B |
| 18 | SNY | Sanofi | 116.92B | 0.71% | 2,245,309 | 54.85B |
| 19 | GSK | GSK plc | 116.08B | 2.14% | 2,985,859 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 112.22B | 1.27% | 1,025,174 | 12.00B |
| 21 | MDT | Medtronic plc | 110.66B | 0.63% | 10,460,209 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 109.10B | 1.04% | 960,764 | 75.60B |
| 23 | MCK | McKesson Corporation | 106.12B | -0.11% | 833,172 | 397.96B |
| 24 | CVS | CVS Health Corporation | 99.07B | 0.66% | 8,683,282 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 95.46B | 1.28% | 12,088,812 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.02B | 0.61% | 512,955 | 14.34B |
| 27 | CI | The Cigna Group | 73.47B | 0.82% | 1,898,905 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 70.96B | 2.29% | 1,331,069 | 199.13B |
| 29 | COR | Cencora, Inc. | 63.72B | 1.61% | 1,670,789 | 325.78B |
| 30 | MDLN | Medline Inc. | 62.58B | 1.49% | 7,075,333 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.82B | 0.22% | 2,574,746 | 28.48B |
| 32 | ARGX | argenx SE | 52.70B | 2.50% | 235,928 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 51.46B | 2.81% | 6,181,346 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 50.36B | 0.42% | 1,962,303 | 244.67B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.80B | 3.39% | 493,502 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 46.69B | 2.45% | 5,555,097 | 6.07B |
| 37 | BDX | Becton, Dickinson and Company | 45.14B | 2.40% | 2,823,726 | 21.92B |
| 38 | HLN | Haleon plc | 43.34B | 1.67% | 6,796,780 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.07B | -3.27% | 1,495,251 | 3.71B |
| 40 | ALC | Alcon Inc. | 39.96B | 2.23% | 1,224,394 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 37.73B | 3.65% | 4,512,225 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 35.92B | 0.99% | 206,312 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 34.44B | 3.06% | 1,582,339 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 34.07B | 1.99% | 3,460,993 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.09B | 1.51% | 776,797 | 5.40B |
| 46 | WAT | Waters Corporation | 32.18B | 2.74% | 330,236 | 3.17B |
| 47 | RVMD | Revolution Medicines, Inc. | 31.26B | -0.43% | 4,758,569 | - |
| 48 | INSM | Insmed Incorporated | 31.19B | 1.18% | 2,048,418 | 606.42M |
| 49 | RPRX | Royalty Pharma plc | 29.64B | 3.14% | 3,036,197 | 2.38B |
| 50 | IQV | IQVIA Holdings Inc. | 29.62B | 2.62% | 1,257,695 | 16.31B |
| 51 | NTRA | Natera, Inc. | 29.54B | 6.27% | 1,423,101 | 2.31B |
| 52 | PHG | Koninklijke Philips N.V. | 28.47B | 3.74% | 945,603 | 20.94B |
| 53 | VEEV | Veeva Systems Inc. | 27.43B | 0.16% | 2,172,676 | 3.20B |
| 54 | MTD | Mettler-Toledo International Inc. | 27.14B | 3.85% | 88,617 | 4.03B |
| 55 | BIIB | Biogen Inc. | 26.03B | 0.76% | 1,239,445 | 9.89B |
| 56 | BNTX | BioNTech SE | 26.03B | 0.78% | 777,359 | 3.37B |
| 57 | UTHR | United Therapeutics Corporation | 25.79B | 1.36% | 682,459 | 3.18B |
| 58 | DXCM | DexCom, Inc. | 24.69B | 4.49% | 4,282,107 | 4.66B |
| 59 | HUM | Humana Inc. | 24.63B | 2.18% | 1,466,545 | 129.66B |
| 60 | LH | Labcorp Holdings Inc. | 22.25B | 1.62% | 549,971 | 13.95B |
| 61 | STE | STERIS plc | 22.14B | 2.65% | 463,669 | 5.83B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.59B | 1.86% | 1,000,041 | 11.04B |
| 63 | ROIV | Roivant Sciences Ltd. | 21.35B | 2.19% | 6,502,845 | 13.31M |
| 64 | MRNA | Moderna, Inc. | 21.30B | -1.76% | 8,301,950 | 1.94B |
| 65 | ILMN | Illumina, Inc. | 20.43B | 1.34% | 1,537,132 | 4.34B |
| 66 | WST | West Pharmaceutical Services, Inc. | 19.71B | 1.45% | 645,564 | 3.07B |
| 67 | SMMT | Summit Therapeutics Inc. | 19.50B | 2.99% | 4,425,614 | - |
| 68 | INCY | Incyte Corporation | 19.47B | 2.62% | 1,529,408 | 5.14B |
| 69 | CNC | Centene Corporation | 18.77B | -2.13% | 4,140,169 | 176.15B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 18.35B | - | 1,164,019 | 8.23B |
| 71 | GMAB | Genmab A/S | 17.49B | 0.88% | 2,194,868 | 3.72B |
| 72 | THC | Tenet Healthcare Corporation | 17.10B | 2.42% | 744,297 | 21.31B |
| 73 | VTRS | Viatris Inc. | 17.09B | 4.78% | 8,867,755 | 14.30B |
| 74 | ASND | Ascendis Pharma A/S | 15.10B | 0.63% | 374,402 | 845.52M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 14.88B | -0.98% | 2,044,777 | 502.08M |
| 76 | MEDP | Medpace Holdings, Inc. | 14.87B | 0.96% | 626,232 | 2.53B |
| 77 | SNN | Smith & Nephew plc | 14.68B | 1.57% | 1,080,478 | 6.16B |
| 78 | RGC | Regencell Bioscience Holdings Limited | 14.18B | -6.22% | 148,869 | - |
| 79 | PODD | Insulet Corporation | 14.11B | 1.12% | 864,754 | 2.71B |
| 80 | COO | The Cooper Companies, Inc. | 13.67B | 0.98% | 2,654,972 | 4.15B |
| 81 | ALGN | Align Technology, Inc. | 13.61B | 2.73% | 1,024,811 | 4.03B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.37B | 3.77% | 1,725,789 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 13.06B | 0.20% | 242,001 | 1.40B |
| 84 | GMED | Globus Medical, Inc. | 12.88B | 2.68% | 1,147,598 | 2.94B |
| 85 | FMS | Fresenius Medical Care AG | 12.63B | 2.81% | 682,853 | 23.05B |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 12.52B | 2.83% | 634,761 | 4.27B |
| 87 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | 0.60% | 1,719,445 | 943.71M |
| 88 | SOLV | Solventum Corporation | 12.22B | 2.32% | 614,643 | 8.33B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.20B | 1.38% | 341,215 | 958.40M |
| 90 | GH | Guardant Health, Inc. | 11.85B | 5.44% | 2,558,562 | 982.02M |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.83B | 2.38% | 2,856,314 | 4.72B |
| 92 | ENSG | The Ensign Group, Inc. | 11.69B | 1.21% | 244,256 | 5.06B |
| 93 | EXEL | Exelixis, Inc. | 11.66B | 1.15% | 2,495,856 | 2.32B |
| 94 | UHS | Universal Health Services, Inc. | 11.13B | 2.06% | 399,316 | 17.36B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.12B | 1.84% | 1,731,138 | 3.85B |
| 96 | EHC | Encompass Health Corporation | 10.58B | 0.85% | 714,519 | 5.94B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.51B | 1.00% | 2,070,568 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 10.51B | 4.95% | 792,327 | 2.86B |
| 99 | TEM | Tempus AI, Inc. | 10.01B | 2.66% | 6,098,791 | 1.27B |
| 100 | DVA | DaVita Inc. | 9.88B | -0.15% | 499,161 | 13.64B |
| 101 | ABVX | ABIVAX Société Anonyme | 9.79B | -1.89% | 1,178,885 | 5.37M |
| 102 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.73B | 2.25% | 4,331,889 | 1.09B |
| 103 | BTSG | BrightSpring Health Services, Inc. | 9.69B | 3.21% | 1,306,493 | 12.91B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.67B | 2.61% | 767,408 | 638.50M |
| 105 | BAX | Baxter International Inc. | 9.66B | 3.14% | 8,971,211 | 11.24B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 9.54B | 6.90% | 425,200 | 7.46M |
| 107 | MASI | Masimo Corporation | 9.31B | 0.06% | 453,981 | 1.53B |
| 108 | TECH | Bio-Techne Corporation | 9.27B | 3.26% | 1,924,845 | 1.22B |
| 109 | ICLR | ICON Public Limited Company | 9.14B | 3.55% | 1,175,652 | 8.10B |
| 110 | CRL | Charles River Laboratories International, Inc. | 9.07B | 3.92% | 507,734 | 4.02B |
| 111 | HSIC | Henry Schein, Inc. | 9.05B | 2.10% | 1,002,203 | 13.18B |
| 112 | PCVX | Vaxcyte, Inc. | 8.97B | 0.24% | 1,151,529 | - |
| 113 | QGEN | Qiagen N.V. | 8.53B | 0.68% | 1,340,983 | 2.09B |
| 114 | NUVL | Nuvalent, Inc. | 8.46B | 3.61% | 772,509 | - |
| 115 | ATR | AptarGroup, Inc. | 8.33B | 1.82% | 290,275 | 3.78B |
| 116 | CYTK | Cytokinetics, Incorporated | 8.22B | 1.97% | 1,498,973 | 88.04M |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.21B | 3.98% | 1,674,188 | 1.40B |
| 118 | KRYS | Krystal Biotech, Inc. | 8.07B | 3.84% | 327,185 | 389.13M |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 8.07B | 2.72% | 186,518 | 2.58B |
| 120 | IBRX | ImmunityBio, Inc. | 7.95B | 6.21% | 19,714,728 | 113.29M |
| 121 | MOH | Molina Healthcare, Inc. | 7.76B | 0.07% | 994,744 | 43.56B |
| 122 | RGEN | Repligen Corporation | 7.40B | 3.24% | 1,122,326 | 738.26M |
| 123 | HQY | HealthEquity, Inc. | 7.27B | 1.79% | 907,015 | 1.31B |
| 124 | GKOS | Glaukos Corporation | 7.24B | 2.61% | 474,645 | 507.44M |
| 125 | KYMR | Kymera Therapeutics, Inc. | 7.16B | 1.82% | 587,341 | 39.21M |
| 126 | GRFS | Grifols, S.A. | 7.07B | 1.74% | 672,533 | 8.83B |
| 127 | APGE | Apogee Therapeutics, Inc. | 6.81B | 1.82% | 1,229,251 | - |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.76B | 2.17% | 1,006,314 | 46.02M |
| 129 | ACLX | Arcellx, Inc. | 6.75B | -0.04% | 479,537 | 22.29M |
| 130 | HIMS | Hims & Hers Health, Inc. | 6.57B | 6.78% | 58,886,786 | 2.35B |
| 131 | BLTE | Belite Bio, Inc | 6.51B | 4.68% | 171,752 | - |
| 132 | SYRE | Spyre Therapeutics, Inc. | 6.30B | 4.75% | 2,126,322 | - |
| 133 | CGON | CG Oncology, Inc. | 6.20B | 10.69% | 1,765,030 | 4.04M |
| 134 | BRKR | Bruker Corporation | 6.20B | 4.52% | 1,742,977 | 3.44B |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.33% | 3,773,801 | 15.00M |
| 136 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.08% | 6,389,287 | - |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.06B | 0.66% | 688,556 | 189.76M |
| 138 | COGT | Cogent Biosciences, Inc. | 6.00B | 2.93% | 3,586,756 | - |
| 139 | PTCT | PTC Therapeutics, Inc. | 6.00B | 1.02% | 1,500,435 | 1.73B |
| 140 | BLCO | Bausch + Lomb Corporation | 5.99B | 1.39% | 421,084 | 5.10B |
| 141 | CAI | Caris Life Sciences, Inc. | 5.98B | 3.68% | 1,121,855 | 812.03M |
| 142 | IMVT | Immunovant, Inc. | 5.96B | 7.13% | 3,421,821 | - |
| 143 | CELC | Celcuity Inc. | 5.92B | -2.23% | 492,330 | - |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | 2.18% | 469,968 | 521.31M |
| 145 | ERAS | Erasca, Inc. | 5.91B | 4.28% | 5,254,460 | - |
| 146 | TFX | Teleflex Incorporated | 5.82B | 1.04% | 1,109,620 | 1.99B |
| 147 | AVTR | Avantor, Inc. | 5.76B | 3.15% | 9,884,538 | 6.55B |
| 148 | ALKS | Alkermes plc | 5.74B | 2.27% | 2,225,638 | 1.48B |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.74B | -0.08% | 1,757,048 | - |
| 150 | XENE | Xenon Pharmaceuticals Inc. | 5.70B | 2.17% | 872,229 | 7.50M |
| 151 | CRSP | CRISPR Therapeutics AG | 5.57B | 4.07% | 1,547,731 | 3.51M |
| 152 | PACS | PACS Group, Inc. | 5.53B | 2.53% | 849,880 | 5.29B |
| 153 | LNTH | Lantheus Holdings, Inc. | 5.45B | -0.12% | 422,279 | 1.54B |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.23B | 0.07% | 5,216,649 | 1.00B |
| 155 | TGTX | TG Therapeutics, Inc. | 5.22B | 3.00% | 2,607,357 | 616.29M |
| 156 | CHE | Chemed Corporation | 5.16B | 0.45% | 243,008 | 2.53B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 5.08B | 0.39% | 553,118 | 2.04M |
| 158 | WAY | Waystar Holding Corp. | 4.95B | 1.90% | 3,012,988 | 1.10B |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.91B | 5.00% | 1,734,394 | 761.41M |
| 160 | OSCR | Oscar Health, Inc. | 4.70B | 1.02% | 4,121,842 | 11.70B |
| 161 | RDNT | RadNet, Inc. | 4.69B | 0.50% | 647,524 | 2.04B |
| 162 | SHC | Sotera Health Company | 4.65B | 2.97% | 2,311,018 | 1.16B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 4.62B | 3.84% | 168,959 | 268.09M |
| 164 | DOCS | Doximity, Inc. | 4.56B | 1.90% | 3,836,436 | 637.78M |
| 165 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.07% | 2,211,335 | 634.21M |
| 166 | NVST | Envista Holdings Corporation | 4.54B | 3.34% | 1,589,917 | 2.72B |
| 167 | OPCH | Option Care Health, Inc. | 4.52B | 1.73% | 887,374 | 5.65B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 4.44B | 6.26% | 1,851,844 | 3.02B |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.34B | 1.92% | 2,514,791 | 3.95B |
| 170 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.29B | 5.07% | 928,787 | 7.70M |
| 171 | STVN | Stevanato Group S.p.A. | 4.24B | 3.33% | 231,928 | 1.39B |
| 172 | MMSI | Merit Medical Systems, Inc. | 4.23B | 1.18% | 470,299 | 1.52B |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.08B | -0.87% | 2,243,549 | - |
| 174 | MMED | MiniMed Group, Inc. | 4.05B | 3.00% | 696,649 | 2.89B |
| 175 | IRTC | iRhythm Holdings, Inc. | 4.05B | 2.21% | 398,123 | 747.14M |
| 176 | TMDX | TransMedics Group, Inc. | 4.00B | 6.19% | 978,678 | 605.49M |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.99B | 4.46% | 648,342 | 22.50M |
| 178 | LEGN | Legend Biotech Corporation | 3.92B | 0.43% | 1,809,094 | 1.03B |
| 179 | TNGX | Tango Therapeutics, Inc. | 3.80B | 6.39% | 2,907,856 | 62.38M |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | 4.33% | 8,552,530 | 1.07B |
| 181 | TVTX | Travere Therapeutics, Inc. | 3.77B | 3.11% | 2,057,367 | 490.73M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.69B | 3.96% | 657,158 | - |
| 183 | LIVN | LivaNova PLC | 3.67B | 3.25% | 776,497 | 1.39B |
| 184 | TWST | Twist Bioscience Corporation | 3.67B | 6.37% | 1,519,434 | 391.56M |
| 185 | BLLN | BillionToOne, Inc. | 3.65B | 0.77% | 493,879 | 305.11M |
| 186 | GPCR | Structure Therapeutics Inc. | 3.60B | -5.14% | 916,770 | - |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.57B | - | 301,044 | 803.79M |
| 188 | LQDA | Liquidia Corporation | 3.48B | -4.66% | 2,192,067 | 158.32M |
| 189 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.44B | -0.93% | 1,013,417 | 677.56M |
| 190 | ORKA | Oruka Therapeutics, Inc. | 3.41B | 2.76% | 1,213,058 | - |
| 191 | HNGE | Hinge Health, Inc. | 3.41B | 0.93% | 483,186 | 587.86M |
| 192 | DYN | Dyne Therapeutics, Inc. | 3.37B | 2.51% | 2,674,162 | - |
| 193 | TXG | 10x Genomics, Inc. | 3.33B | 3.33% | 2,036,644 | 642.82M |
| 194 | BKD | Brookdale Senior Living Inc. | 3.27B | -2.76% | 2,783,795 | 3.05B |
| 195 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.68% | 1,461,979 | - |
| 196 | ICUI | ICU Medical, Inc. | 3.25B | 3.11% | 257,046 | 2.23B |
| 197 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.21B | 1.43% | 3,278,814 | 588.99M |
| 198 | ALMS | Alumis Inc. | 3.18B | -0.04% | 1,179,172 | 24.05M |
| 199 | BEAM | Beam Therapeutics Inc. | 3.12B | 3.49% | 1,936,991 | 139.74M |
| 200 | ITGR | Integer Holdings Corporation | 3.07B | 2.07% | 207,328 | 1.85B |
| 201 | KLRA | Kailera Therapeutics, Inc. | 3.07B | 62.50% | 8,109,031 | - |
| 202 | WRBY | Warby Parker Inc. | 3.04B | 7.29% | 1,709,525 | 871.91M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | 1.41% | 1,158,462 | 376.07M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.04B | 2.80% | 517,098 | 247.00M |
| 205 | VERA | Vera Therapeutics, Inc. | 3.03B | 0.14% | 1,168,147 | - |
| 206 | PRVA | Privia Health Group, Inc. | 3.02B | 2.21% | 803,271 | 2.12B |
| 207 | RLAY | Relay Therapeutics, Inc. | 3.00B | 4.03% | 2,360,006 | 15.36M |
| 208 | IDYA | IDEAYA Biosciences, Inc. | 2.98B | 4.31% | 1,267,857 | 218.71M |
| 209 | SUPN | Supernus Pharmaceuticals, Inc. | 2.96B | 4.41% | 797,784 | 718.95M |
| 210 | CON | Concentra Group Holdings Parent, Inc. | 2.94B | 2.37% | 248,036 | 2.16B |
| 211 | ELVN | Enliven Therapeutics, Inc. | 2.88B | 6.11% | 1,383,702 | - |
| 212 | HAE | Haemonetics Corporation | 2.86B | 2.51% | 658,537 | 1.32B |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.86B | -0.71% | 852,904 | 451.36M |
| 214 | MANE | Veradermics, Incorporated | 2.85B | 2.93% | 261,265 | - |
| 215 | IMNM | Immunome, Inc. | 2.79B | 5.89% | 1,022,198 | 6.94M |
| 216 | KOD | Kodiak Sciences Inc. | 2.77B | 11.11% | 1,040,569 | - |
| 217 | PBH | Prestige Consumer Healthcare Inc. | 2.75B | 1.89% | 244,831 | 1.10B |
| 218 | IRON | Disc Medicine, Inc. | 2.74B | 3.34% | 456,912 | - |
| 219 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.40% | 3,487,199 | 190.41M |
| 220 | ZLAB | Zai Lab Limited | 2.73B | 2.94% | 1,451,683 | 460.16M |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.71B | 2.04% | 1,481,146 | 1.55M |
| 222 | HTFL | HeartFlow, Inc. | 2.69B | 5.17% | 1,110,934 | 176.03M |
| 223 | VCYT | Veracyte, Inc. | 2.69B | 2.33% | 1,666,081 | 517.15M |
| 224 | LFST | LifeStance Health Group, Inc. | 2.69B | 3.30% | 1,403,981 | 1.42B |
| 225 | ADMA | ADMA Biologics, Inc. | 2.62B | 2.51% | 4,626,363 | 510.17M |
| 226 | NHC | National HealthCare Corporation | 2.62B | 4.14% | 77,320 | 1.52B |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.60B | 2.43% | 165,995 | 249.60M |
| 228 | HCM | HUTCHMED (China) Limited | 2.56B | 2.60% | 31,649 | 548.51M |
| 229 | OGN | Organon & Co. | 2.54B | 4.61% | 7,001,749 | 6.22B |
| 230 | MLYS | Mineralys Therapeutics, Inc. | 2.52B | 0.07% | 1,036,915 | - |
| 231 | XRAY | DENTSPLY SIRONA Inc. | 2.50B | 3.47% | 3,349,303 | 3.68B |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.48B | 0.41% | 2,966,871 | 3.31B |
| 233 | AAPG | Ascentage Pharma Group International | 2.48B | 0.88% | 1,624 | 82.08M |
| 234 | NKTR | Nektar Therapeutics | 2.43B | 1.04% | 507,922 | 55.23M |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | 2.43B | 1.18% | 1,725,498 | 673.00M |
| 236 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.38B | -0.21% | 3,656,584 | 874.84M |
| 237 | GRDN | Guardian Pharmacy Services, Inc. | 2.38B | 1.60% | 315,527 | 1.45B |
| 238 | PAHC | Phibro Animal Health Corporation | 2.31B | 5.92% | 175,008 | 1.46B |
| 239 | SRPT | Sarepta Therapeutics, Inc. | 2.26B | 1.79% | 2,510,660 | 2.20B |
| 240 | DFTX | Definium Therapeutics, Inc. | 2.26B | 0.98% | 1,904,866 | - |
| 241 | ADPT | Adaptive Biotechnologies Corporation | 2.23B | 2.77% | 1,592,692 | 276.98M |
| 242 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.09% | 2,241,210 | 158.18M |
| 243 | STOK | Stoke Therapeutics, Inc. | 2.20B | 5.46% | 894,293 | 184.42M |
| 244 | BHC | Bausch Health Companies Inc. | 2.20B | 1.37% | 1,602,242 | 10.27B |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.14B | 10.84% | 5,308,526 | 51.95M |
| 246 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | 1.76% | 1,658,047 | 172.35M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 1.39% | 754,507 | 283.06M |
| 248 | GRAL | GRAIL, Inc. | 2.12B | 4.53% | 739,985 | 147.17M |
| 249 | MESO | Mesoblast Limited | 2.09B | 2.30% | 163,751 | 65.38M |
| 250 | NEOG | Neogen Corporation | 2.07B | 2.92% | 2,095,323 | 870.56M |
| 251 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | 0.63% | 673,042 | 54.03M |
| 252 | ZYME | Zymeworks Inc. | 2.05B | 2.21% | 487,203 | 105.97M |
| 253 | SEM | Select Medical Holdings Corporation | 2.03B | - | 2,136,884 | 5.45B |
| 254 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.03B | 3.55% | 1,592,267 | -665.00K |
| 255 | CAPR | Capricor Therapeutics, Inc. | 2.01B | 0.32% | 772,237 | 11.13M |
| 256 | AXGN | Axogen, Inc. | 2.00B | 3.02% | 2,750,301 | 225.21M |
| 257 | RXRX | Recursion Pharmaceuticals, Inc. | 2.00B | 5.00% | 14,266,693 | 74.68M |
| 258 | ESTA | Establishment Labs Holdings Inc. | 1.97B | 3.98% | 589,056 | 211.08M |
| 259 | SION | Sionna Therapeutics, Inc. | 1.96B | -3.76% | 508,774 | - |
| 260 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 4.75% | 7,258,604 | - |
| 261 | ANAB | AnaptysBio, Inc. | 1.94B | 0.91% | 623,861 | 234.60M |
| 262 | WGS | GeneDx Holdings Corp. | 1.93B | 0.83% | 678,713 | 427.54M |
| 263 | GLPG | Galapagos NV | 1.92B | 1.46% | 91,081 | 1.31B |
| 264 | TYRA | Tyra Biosciences, Inc. | 1.92B | 1.25% | 1,345,729 | - |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.90B | 0.43% | 1,498,726 | - |
| 266 | MD | Pediatrix Medical Group, Inc. | 1.87B | 3.87% | 317,483 | 1.91B |
| 267 | PHVS | Pharvaris N.V. | 1.87B | -0.76% | 149,201 | - |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.86B | 4.69% | 303,744 | - |
| 269 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | 8.07% | 6,163,537 | 9.77M |
| 270 | ANIP | ANI Pharmaceuticals, Inc. | 1.84B | 3.65% | 431,061 | 883.37M |
| 271 | AORT | Artivion, Inc. | 1.83B | 2.67% | 201,592 | 441.33M |
| 272 | VCEL | Vericel Corporation | 1.82B | 5.66% | 441,121 | 276.26M |
| 273 | NRIX | Nurix Therapeutics, Inc. | 1.81B | 4.91% | 853,412 | 71.78M |
| 274 | INVA | Innoviva, Inc. | 1.80B | 2.71% | 683,936 | 411.33M |
| 275 | SGRY | Surgery Partners, Inc. | 1.79B | 4.24% | 1,036,905 | 3.31B |
| 276 | NUVB | Nuvation Bio Inc. | 1.77B | 5.61% | 2,212,412 | 62.90M |
| 277 | NTLA | Intellia Therapeutics, Inc. | 1.77B | 5.58% | 2,732,029 | 67.67M |
| 278 | OMCL | Omnicell, Inc. | 1.74B | 1.81% | 293,513 | 1.18B |
| 279 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | 1.94% | 670,851 | 868.45M |
| 280 | AHG | Akso Health Group | 1.73B | -5.40% | 193,858 | 14.84M |
| 281 | AHCO | AdaptHealth Corp. | 1.72B | 0.64% | 1,348,204 | 3.24B |
| 282 | VIR | Vir Biotechnology, Inc. | 1.72B | 4.07% | 1,919,257 | 68.56M |
| 283 | ADUS | Addus HomeCare Corporation | 1.71B | 1.06% | 241,662 | 1.42B |
| 284 | ATEC | Alphatec Holdings, Inc. | 1.68B | 2.59% | 2,560,309 | 764.16M |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.66B | 2.02% | 462,072 | 911.98M |
| 286 | BHVN | Biohaven Ltd. | 1.65B | 9.69% | 2,280,748 | - |
| 287 | NBTX | Nanobiotix S.A. | 1.64B | 4.10% | 60,543 | 38.27M |
| 288 | OCS | Oculis Holding AG | 1.62B | 0.33% | 366,236 | 1.51M |
| 289 | PRGO | Perrigo Company plc | 1.62B | 3.33% | 1,439,056 | 4.25B |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.62B | -2.12% | 608,839 | 336.39M |
| 291 | MBX | MBX Biosciences, Inc. | 1.60B | 1.66% | 304,632 | - |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.60B | -1.48% | 388,890 | - |
| 293 | IMCR | Immunocore Holdings plc | 1.59B | 0.22% | 782,946 | 400.02M |
| 294 | PLSE | Pulse Biosciences, Inc. | 1.59B | 14.09% | 209,428 | 350.00K |
| 295 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | 1.58% | 9,416,722 | 263.50M |
| 296 | GENB | Generate Biomedicines, Inc. | 1.59B | -1.27% | 270,953 | 31.89M |
| 297 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | 5.78% | 890,302 | 123.67M |
| 298 | ARDX | Ardelyx, Inc. | 1.58B | 2.71% | 2,891,738 | 407.32M |
| 299 | BCAX | Bicara Therapeutics Inc. | 1.57B | 0.33% | 467,153 | - |
| 300 | UFPT | UFP Technologies, Inc. | 1.56B | 4.30% | 229,262 | 602.80M |
| 301 | ASTH | Astrana Health, Inc. | 1.56B | 2.94% | 748,437 | 3.18B |
| 302 | HROW | Harrow, Inc. | 1.55B | 2.09% | 776,938 | 272.30M |
| 303 | ENOV | Enovis Corporation | 1.51B | 4.44% | 1,052,474 | 2.25B |
| 304 | VRDN | Viridian Therapeutics, Inc. | 1.51B | 0.95% | 1,582,032 | 70.85M |
| 305 | ATRC | AtriCure, Inc. | 1.50B | 2.91% | 1,022,780 | 534.53M |
| 306 | IMTX | Immatics N.V. | 1.50B | 2.76% | 358,277 | 56.67M |
| 307 | AVAH | Aveanna Healthcare Holdings Inc. | 1.47B | 0.89% | 1,179,255 | 2.43B |
| 308 | ATAI | AtaiBeckley Inc. | 1.47B | -1.47% | 5,764,305 | 4.09M |
| 309 | ALMR | Alamar Biosciences, Inc. | 1.47B | 29.41% | 4,892,797 | 74.21M |
| 310 | OLMA | Olema Pharmaceuticals, Inc. | 1.47B | 2.06% | 800,128 | - |
| 311 | SVRA | Savara Inc. | 1.47B | 2.48% | 1,719,075 | - |
| 312 | NVCR | NovoCure Limited | 1.46B | 1.66% | 914,562 | 655.35M |
| 313 | NVAX | Novavax, Inc. | 1.44B | 2.31% | 2,413,179 | 1.12B |
| 314 | PGNY | Progyny, Inc. | 1.42B | 1.06% | 860,234 | 1.29B |
| 315 | ARDT | Ardent Health, Inc. | 1.42B | 4.98% | 494,801 | 6.32B |
| 316 | PRCT | PROCEPT BioRobotics Corporation | 1.42B | 2.53% | 755,532 | 308.05M |
| 317 | TNDM | Tandem Diabetes Care, Inc. | 1.41B | 2.59% | 1,982,821 | 1.01B |
| 318 | WVE | Wave Life Sciences Ltd. | 1.41B | 2.32% | 5,957,241 | 42.73M |
| 319 | PGEN | Precigen, Inc. | 1.41B | 0.76% | 2,503,222 | 9.68M |
| 320 | CRVS | Corvus Pharmaceuticals, Inc. | 1.41B | 11.30% | 2,519,226 | - |
| 321 | MAZE | Maze Therapeutics, Inc. | 1.40B | 4.54% | 1,230,796 | 2.50M |
| 322 | BFLY | Butterfly Network, Inc. | 1.39B | 3.02% | 5,821,943 | 97.61M |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.35B | 2.40% | 440,449 | 1.84B |
| 324 | KMTS | Kestra Medical Technologies, Ltd. | 1.33B | 11.76% | 296,960 | 83.72M |
| 325 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 5.40% | 226,776 | - |
| 326 | MLTX | MoonLake Immunotherapeutics | 1.32B | 3.09% | 858,333 | - |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.31B | 0.10% | 397,662 | - |
| 328 | ZBIO | Zenas BioPharma, Inc. | 1.30B | 0.30% | 316,944 | 10.00M |
| 329 | INBX | Inhibrx Biosciences, Inc. | 1.29B | 6.16% | 416,564 | 1.30M |
| 330 | DBVT | DBV Technologies S.A. | 1.27B | 3.54% | 236,644 | 5.64M |
| 331 | EYPT | EyePoint, Inc. | 1.25B | 0.81% | 1,264,319 | 31.37M |
| 332 | PHAR | Pharming Group N.V. | 1.24B | 0.06% | 7,021 | 376.13M |
| 333 | STAA | STAAR Surgical Company | 1.24B | 1.87% | 775,542 | 239.44M |
| 334 | ABCL | AbCellera Biologics Inc. | 1.22B | 4.70% | 4,674,871 | 75.13M |
| 335 | IRMD | IRADIMED CORPORATION | 1.20B | 1.99% | 82,755 | 83.81M |
| 336 | NNNN | Anbio Biotechnology | 1.19B | -2.34% | 48,489 | 8.65M |
| 337 | IVA | Inventiva S.A. | 1.18B | 0.71% | 446,889 | 7.94M |
| 338 | CNMD | CONMED Corporation | 1.18B | 3.09% | 197,718 | 1.37B |
| 339 | SEPN | Septerna, Inc. | 1.17B | 4.56% | 391,394 | 45.95M |
| 340 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -2.06% | 220,488 | 773.34M |
| 341 | EVO | Evotec SE | 1.15B | 1.24% | 63,467 | 925.65M |
| 342 | AZTA | Azenta, Inc. | 1.15B | 2.96% | 458,850 | 595.03M |
| 343 | CLOV | Clover Health Investments, Corp. | 1.15B | 1.39% | 5,222,671 | 1.92B |
| 344 | AVNS | Avanos Medical, Inc. | 1.15B | -0.16% | 1,511,570 | 701.20M |
| 345 | GHRS | GH Research PLC | 1.14B | 3.38% | 139,385 | - |
| 346 | ALVO | Alvotech | 1.13B | -0.28% | 211,831 | 588.90M |
| 347 | JBIO | Jade Biosciences, Inc. | 1.13B | 4.43% | 703,949 | - |
| 348 | AKTS | Aktis Oncology, Inc. | 1.12B | 8.87% | 205,250 | 6.50M |
| 349 | INNV | InnovAge Holding Corp. | 1.12B | -1.55% | 269,957 | 915.37M |
| 350 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 4.15% | 396,968 | 780.57M |
| 351 | QURE | uniQure N.V. | 1.10B | 4.58% | 1,902,217 | 16.10M |
| 352 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | 4.08% | 1,246,142 | 291.85M |
| 353 | URGN | UroGen Pharma Ltd. | 1.10B | 5.38% | 602,779 | 109.79M |
| 354 | CDNA | CareDx, Inc. | 1.10B | -4.46% | 1,388,992 | 379.81M |
| 355 | NEO | NeoGenomics, Inc. | 1.09B | 2.33% | 1,634,476 | 727.33M |
| 356 | CMPX | Compass Therapeutics, Inc. | 1.08B | -8.12% | 3,412,734 | 850.00K |
| 357 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | 5.08% | 1,457,621 | - |
| 358 | GERN | Geron Corporation | 1.08B | -0.59% | 20,689,355 | 183.88M |
| 359 | PNTG | The Pennant Group, Inc. | 1.07B | 1.05% | 109,047 | 947.71M |
| 360 | ANNX | Annexon, Inc. | 1.05B | 3.32% | 3,001,015 | - |
| 361 | KALV | KalVista Pharmaceuticals, Inc. | 1.05B | 4.70% | 1,088,286 | 73.62M |
| 362 | PHAT | Phathom Pharmaceuticals, Inc. | 1.05B | 4.60% | 788,914 | 175.11M |
| 363 | CTMX | CytomX Therapeutics, Inc. | 1.04B | -1.43% | 4,936,589 | 76.20M |
| 364 | BLFS | BioLife Solutions, Inc. | 1.04B | 3.12% | 295,877 | 96.21M |
| 365 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.04B | 4.91% | 537,816 | 719.89M |
| 366 | TDOC | Teladoc Health, Inc. | 1.03B | -2.23% | 4,113,650 | 2.53B |
| 367 | CRON | Cronos Group Inc. | 1.02B | 0.37% | 944,521 | 146.59M |
| 368 | PCRX | Pacira BioSciences, Inc. | 1.00B | 3.60% | 471,467 | 726.41M |
| 369 | EVMN | Evommune, Inc. | 988.70M | 2.54% | 212,080 | 13.00M |
| 370 | SSII | SS Innovations International, Inc. | 977.71M | -0.81% | 26,550 | 42.48M |
| 371 | ANRO | Alto Neuroscience, Inc. | 971.66M | 6.37% | 336,915 | - |
| 372 | FTRE | Fortrea Holdings Inc. | 969.13M | 2.73% | 750,058 | 2.72B |
| 373 | OMER | Omeros Corporation | 967.63M | 7.18% | 1,947,250 | - |
| 374 | JANX | Janux Therapeutics, Inc. | 962.36M | 4.15% | 1,148,090 | 10.00M |
| 375 | XNCR | Xencor, Inc. | 957.80M | 4.90% | 877,127 | 125.58M |
| 376 | CERT | Certara, Inc. | 954.45M | 1.06% | 2,487,703 | 418.84M |
| 377 | OPK | OPKO Health, Inc. | 941.24M | 2.48% | 1,297,228 | 606.88M |
| 378 | SANA | Sana Biotechnology, Inc. | 939.37M | 1.44% | 3,258,950 | - |
| 379 | SLS | SELLAS Life Sciences Group, Inc. | 937.42M | 5.88% | 5,256,376 | - |
| 380 | MGTX | MeiraGTx Holdings plc | 936.68M | 6.75% | 2,283,256 | 81.39M |
| 381 | LMRI | Lumexa Imaging Holdings, Inc. | 928.42M | 6.68% | 1,051,105 | 1.02B |
| 382 | INMD | InMode Ltd. | 928.21M | 2.23% | 872,447 | 370.50M |
| 383 | ABUS | Arbutus Biopharma Corporation | 922.66M | 0.85% | 1,052,579 | 14.08M |
| 384 | CGEM | Cullinan Therapeutics, Inc. | 911.52M | 2.17% | 841,381 | - |
| 385 | SDGR | Schrödinger, Inc. | 911.00M | 2.32% | 2,542,204 | 255.87M |
| 386 | VOR | Vor Biopharma Inc. | 898.94M | 10.82% | 2,148,054 | - |
| 387 | TBPH | Theravance Biopharma, Inc. | 887.22M | 2.68% | 436,111 | 107.46M |
| 388 | DRUG | Bright Minds Biosciences Inc. | 884.14M | 1.41% | 115,200 | - |
| 389 | MNKD | MannKind Corporation | 876.98M | 3.27% | 2,795,456 | 348.97M |
| 390 | LBRX | LB Pharmaceuticals Inc | 875.16M | 7.92% | 298,252 | - |
| 391 | BVS | Bioventus Inc. | 874.79M | 1.06% | 547,202 | 568.09M |
| 392 | MRVI | Maravai LifeSciences Holdings, Inc. | 871.46M | -0.59% | 2,726,511 | 185.74M |
| 393 | IART | Integra LifeSciences Holdings Corporation | 868.22M | 2.77% | 719,569 | 1.64B |
| 394 | TALK | Talkspace, Inc. | 865.45M | 0.19% | 1,492,549 | 228.87M |
| 395 | QDEL | QuidelOrtho Corporation | 865.32M | 0.20% | 4,824,182 | 2.73B |
| 396 | KURA | Kura Oncology, Inc. | 859.22M | 8.28% | 3,309,399 | 67.48M |
| 397 | CMPS | COMPASS Pathways plc | 858.63M | - | 1,950,529 | - |
| 398 | SLDB | Solid Biosciences Inc. | 849.15M | 2.86% | 976,996 | - |
| 399 | SGP | SpyGlass Pharma, Inc. | 833.66M | -0.36% | 43,789 | - |
| 400 | OMDA | Omada Health, Inc. | 833.21M | 5.76% | 1,216,199 | 260.21M |
| 401 | FBRX | Forte Biosciences, Inc. | 830.30M | 7.92% | 445,166 | - |
| 402 | ALLO | Allogene Therapeutics, Inc. | 822.11M | 0.84% | 11,542,985 | 22.00K |
| 403 | BIOA | BioAge Labs, Inc. | 820.58M | 8.83% | 508,205 | 9.00M |
| 404 | SPRY | ARS Pharmaceuticals, Inc. | 812.25M | - | 959,321 | 84.28M |
| 405 | DSGN | Design Therapeutics, Inc. | 810.68M | 5.08% | 302,597 | - |
| 406 | CBLL | CeriBell, Inc. | 797.62M | 2.17% | 244,046 | 89.06M |
| 407 | TLRY | Tilray Brands, Inc. | 797.32M | 1.03% | 3,350,793 | 858.28M |
| 408 | LXRX | Lexicon Pharmaceuticals, Inc. | 792.28M | 1.63% | 3,112,875 | 49.80M |
| 409 | RLMD | Relmada Therapeutics, Inc. | 784.56M | 6.86% | 2,384,568 | - |
| 410 | AMN | AMN Healthcare Services, Inc. | 780.47M | -1.27% | 1,145,018 | 2.73B |
| 411 | GDRX | GoodRx Holdings, Inc. | 777.64M | -3.40% | 2,271,122 | 796.85M |
| 412 | CSTL | Castle Biosciences, Inc. | 758.91M | 2.00% | 214,812 | 344.23M |
| 413 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 748.31M | 1.41% | 586,321 | - |
| 414 | GYRE | Gyre Therapeutics, Inc. | 739.64M | 2.53% | 89,959 | 116.59M |
| 415 | NUTX | Nutex Health Inc. | 735.72M | 3.75% | 243,337 | 875.26M |
| 416 | TENX | Tenax Therapeutics, Inc. | 726.84M | 7.20% | 764,310 | - |
| 417 | IRWD | Ironwood Pharmaceuticals, Inc. | 722.35M | 2.31% | 1,957,638 | 296.15M |
| 418 | CBIO | Crescent Biopharma, Inc. | 706.79M | 9.41% | 291,521 | 10.84M |
| 419 | DRTS | Alpha Tau Medical Ltd. | 706.72M | 0.75% | 250,364 | - |
| 420 | PSNL | Personalis, Inc. | 704.48M | 1.05% | 1,399,940 | 69.65M |
| 421 | ARVN | Arvinas, Inc. | 703.57M | - | 758,990 | 262.60M |
| 422 | EHAB | Enhabit, Inc. | 695.92M | -0.07% | 945,166 | 1.06B |
| 423 | ETON | Eton Pharmaceuticals, Inc. | 683.20M | 2.50% | 276,237 | 79.95M |
| 424 | PRME | Prime Medicine, Inc. | 674.67M | 3.81% | 1,894,229 | 4.63M |
| 425 | OCGN | Ocugen, Inc. | 672.42M | 3.11% | 4,536,706 | 4.41M |
| 426 | PROK | ProKidney Corp. | 658.18M | 11.79% | 1,272,335 | 893.00K |
| 427 | EIKN | Eikon Therapeutics, Inc. | 644.25M | 5.87% | 202,933 | - |
| 428 | ANL | Adlai Nortye Ltd. | 640.40M | 16.95% | 1,387,283 | 5.00M |
| 429 | HSTM | HealthStream, Inc. | 637.91M | 1.73% | 172,250 | 304.06M |
| 430 | BWAY | BrainsWay Ltd. | 626.56M | 3.13% | 85,371 | 52.23M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 626.45M | 2.60% | 1,215,663 | 106.47M |
| 432 | SIBN | SI-BONE, Inc. | 622.29M | 3.07% | 372,991 | 200.93M |
| 433 | KYTX | Kyverna Therapeutics, Inc. | 600.32M | 4.20% | 919,228 | - |
| 434 | RIGL | Rigel Pharmaceuticals, Inc. | 599.08M | 2.08% | 418,083 | 294.28M |
| 435 | AVR | Anteris Technologies Global Corp. | 592.64M | 1.85% | 930,126 | 1.91M |
| 436 | CTKB | Cytek Biosciences, Inc. | 592.62M | - | 578,295 | 201.49M |
| 437 | ACRS | Aclaris Therapeutics, Inc. | 590.73M | 6.78% | 1,091,269 | 7.83M |
| 438 | PRTA | Prothena Corporation plc | 586.78M | 3.61% | 486,483 | 9.68M |
| 439 | TCMD | Tactile Systems Technology, Inc. | 585.37M | 2.39% | 168,649 | 329.52M |
| 440 | CRMD | CorMedix Inc. | 584.18M | 3.65% | 1,263,953 | 311.71M |
| 441 | EMBC | Embecta Corp. | 579.17M | 2.84% | 801,678 | 1.08B |
| 442 | BBNX | Beta Bionics, Inc. | 578.41M | 6.57% | 1,583,582 | 100.25M |
| 443 | VSTM | Verastem, Inc. | 578.01M | 3.79% | 2,524,372 | 30.91M |
| 444 | STTK | Shattuck Labs, Inc. | 569.13M | 2.45% | 312,455 | 1.00M |
| 445 | LYEL | Lyell Immunopharma, Inc. | 560.11M | 1.31% | 93,784 | 36.00K |
| 446 | PHR | Phreesia, Inc. | 557.20M | - | 1,273,244 | 480.59M |
| 447 | TECX | Tectonic Therapeutic, Inc. | 554.10M | -0.57% | 175,199 | - |
| 448 | AGMB | AgomAb Therapeutics NV | 552.19M | 1.16% | 295,546 | - |
| 449 | FULC | Fulcrum Therapeutics, Inc. | 552.12M | 3.75% | 1,037,200 | 80.00M |
| 450 | ZURA | Zura Bio Limited | 551.26M | 1.75% | 618,862 | - |
| 451 | IMMX | Immix Biopharma, Inc. | 548.68M | 3.92% | 1,006,028 | - |
| 452 | ABSI | Absci Corporation | 547.82M | 10.84% | 6,025,129 | 2.80M |
| 453 | NPCE | NeuroPace, Inc. | 545.07M | 4.65% | 79,203 | 99.99M |
| 454 | ADCT | ADC Therapeutics SA | 543.75M | -2.28% | 466,611 | 81.36M |
| 455 | UPB | Upstream Bio, Inc. | 543.66M | -1.09% | 508,713 | 2.85M |
| 456 | ENGN | enGene Therapeutics Inc. | 540.60M | -0.12% | 842,967 | - |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 535.53M | 4.27% | 894,694 | 85.21M |
| 458 | VALN | Valneva SE | 531.45M | -0.17% | 19,804 | 205.07M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 527.23M | 1.41% | 1,066,628 | 44.55M |
| 460 | ESPR | Esperion Therapeutics, Inc. | 523.89M | -0.49% | 6,618,013 | 403.14M |
| 461 | STRO | Sutro Biopharma, Inc. | 522.70M | 7.50% | 296,978 | 102.48M |
| 462 | LXEO | Lexeo Therapeutics, Inc. | 511.94M | 5.02% | 654,351 | - |
| 463 | PACB | Pacific Biosciences of California, Inc. | 510.38M | 3.68% | 8,483,871 | 160.01M |
| 464 | OFIX | Orthofix Medical Inc. | 510.24M | 2.58% | 206,285 | 822.31M |
| 465 | MDXG | MiMedx Group, Inc. | 507.35M | -0.44% | 1,995,322 | 418.63M |
| 466 | CTNM | Contineum Therapeutics, Inc. | 505.16M | 1.73% | 424,165 | - |
| 467 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 468 | TRDA | Entrada Therapeutics, Inc. | 503.64M | 3.17% | 94,785 | 25.42M |
| 469 | VREX | Varex Imaging Corporation | 503.45M | 3.53% | 151,739 | 854.40M |
| 470 | AGL | agilon health, inc. | 498.67M | -2.88% | 431,325 | 5.93B |
| 471 | LRMR | Larimar Therapeutics, Inc. | 498.64M | 1.69% | 764,160 | - |
| 472 | IVVD | Invivyd, Inc. | 492.08M | 1.75% | 1,896,324 | 53.43M |
| 473 | RGNX | REGENXBIO Inc. | 489.85M | 3.26% | 453,865 | 170.44M |
| 474 | KMDA | Kamada Ltd. | 486.21M | 3.03% | 51,356 | 180.46M |
| 475 | BNTC | Benitec Biopharma Inc. | 482.31M | 4.61% | 136,756 | - |
| 476 | CATX | Perspective Therapeutics, Inc. | 478.52M | -1.41% | 982,361 | 884.00K |
| 477 | MYGN | Myriad Genetics, Inc. | 475.02M | 1.60% | 967,836 | 824.50M |
| 478 | XOMA | XOMA Royalty Corporation | 474.37M | 0.50% | 174,154 | 52.15M |
| 479 | VTVT | vTv Therapeutics Inc. | 473.05M | 3.73% | 30,440 | 17.00K |
| 480 | FLGT | Fulgent Genetics, Inc. | 468.73M | 0.74% | 377,234 | 322.67M |
| 481 | AURA | Aura Biosciences, Inc. | 467.66M | 3.26% | 427,522 | - |
| 482 | DNA | Ginkgo Bioworks Holdings, Inc. | 467.40M | 1.01% | 1,392,410 | 170.16M |
| 483 | IPSC | Century Therapeutics, Inc. | 467.28M | 6.56% | 1,905,103 | 109.16M |
| 484 | CADL | Candel Therapeutics, Inc. | 466.58M | 23.45% | 4,036,589 | - |
| 485 | ASMB | Assembly Biosciences, Inc. | 463.83M | -0.27% | 230,433 | 72.30M |
| 486 | AVIR | Atea Pharmaceuticals, Inc. | 457.32M | 0.70% | 427,715 | - |
| 487 | ALT | Altimmune, Inc. | 455.37M | -0.28% | 2,868,124 | 41.00K |
| 488 | EBS | Emergent BioSolutions Inc. | 454.99M | 2.20% | 499,898 | 742.90M |
| 489 | ANGO | AngioDynamics, Inc. | 452.67M | 3.82% | 928,094 | 313.73M |
| 490 | EPRX | Eupraxia Pharmaceuticals Inc. | 440.89M | -1.39% | 85,764 | - |
| 491 | CLYM | Climb Bio, Inc. | 437.56M | 3.85% | 409,232 | - |
| 492 | CGC | Canopy Growth Corporation | 437.34M | -0.87% | 9,524,693 | 203.04M |
| 493 | PRTC | PureTech Health plc | 436.90M | 0.44% | 6,059 | 6.39M |
| 494 | NGNE | Neurogene Inc. | 433.74M | 8.66% | 325,840 | 925.00K |
| 495 | VNDA | Vanda Pharmaceuticals Inc. | 429.72M | 1.54% | 909,287 | 216.11M |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 426.67M | 0.26% | 2,030,761 | - |
| 497 | LCTX | Lineage Cell Therapeutics, Inc. | 425.94M | 4.27% | 1,813,426 | 14.56M |
| 498 | AUTL | Autolus Therapeutics plc | 425.83M | -0.62% | 2,137,287 | 75.39M |
| 499 | KIDS | OrthoPediatrics Corp. | 423.42M | 1.33% | 201,904 | 236.35M |
| 500 | CYH | Community Health Systems, Inc. | 423.01M | 0.96% | 732,187 | 12.49B |